Optimising resources for international safety data collection and analysis
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Presentation
- By: LINDQUIST, Marie (Uppsala Monitoring Centre, Uppsala, Sweden)
The original aim of pharmacovigilance - to identify previously unknown suspected adverse reactions, mainly to new drug products - covers only a small part of the disease burden related to the use of medicines. Only a broader, holistic look at all the factors leading to adverse patient outcomes on medication will reduce the resulting global.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.